| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/13/2005 | CN1639188A Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 07/13/2005 | CN1639186A Inhibitors of kallikrein |
| 07/13/2005 | CN1639168A Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 07/13/2005 | CN1639164A Nitrogen-containing heterocyclic compound |
| 07/13/2005 | CN1639161A Alkyne-aryl phosphodiesterase-4 inhibitors |
| 07/13/2005 | CN1639159A N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as DDP-IV inhibitors |
| 07/13/2005 | CN1639158A Thiazole derivatives as NPY receptor antagonists |
| 07/13/2005 | CN1639150A 异喹啉衍生物 Isoquinoline derivatives |
| 07/13/2005 | CN1639141A New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 07/13/2005 | CN1639139A 5-phenylthiazole derivatives and use as PI3 kinase inhibitors |
| 07/13/2005 | CN1639132A N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/13/2005 | CN1639126A Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies |
| 07/13/2005 | CN1639125A New inhibitors of histone deacetylase |
| 07/13/2005 | CN1639119A Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 07/13/2005 | CN1638799A Human mast cell-expressed membrane proteins |
| 07/13/2005 | CN1638796A Methods of administering anti-TNF alpha antibodies |
| 07/13/2005 | CN1638792A FGFR agonists |
| 07/13/2005 | CN1638781A Carbon monoxide as a biomarker and therapeutic agent |
| 07/13/2005 | CN1638778A Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer |
| 07/13/2005 | CN1638765A Mediators of Hedgehog signaling pathways, compositions and uses related thereto |
| 07/13/2005 | CN1638760A Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/13/2005 | CN1638759A Pharmaceutical composition comprising a bisphosphonate and a COX-2 inhibitor for the treatment of bone diseases |
| 07/13/2005 | CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 07/13/2005 | CN1638753A Potentiation of therapeutic effects of fatty acids |
| 07/13/2005 | CN1638747A Sustained release pharmaceutical composition |
| 07/13/2005 | CN1638739A Compound for treating assuetude disturbance |
| 07/13/2005 | CN1638650A Composition improving age-related physiological deficits and increasing longevity |
| 07/13/2005 | CN1637016A Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 07/13/2005 | CN1636983A Substituted heterocyclic compounds |
| 07/13/2005 | CN1636980A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 07/13/2005 | CN1636592A Stabilized liquid polypeptide-containing pharmaceutical composition |
| 07/13/2005 | CN1636590A Pharmaceutical preparation containing cyclopeptide and chemotherapeutic agent or angiogenesis inhibitor |
| 07/13/2005 | CN1636578A Chinese kmedicine bolus for treating femoral head necrosis and its prepn process |
| 07/13/2005 | CN1636567A Piperazine derivative used as CCRS antagonist |
| 07/13/2005 | CN1636566A Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 07/13/2005 | CN1636563A 噻唑衍生物 Thiazole derivatives |
| 07/13/2005 | CN1210303C Human apolipoprotein polypeptide and its use in resisting vascular proliferation diseases |
| 07/13/2005 | CN1210279C Thiazolo (4,5-D) pyrimidine compounds |
| 07/13/2005 | CN1210274C Piperazine and piperidine derivatives |
| 07/13/2005 | CN1210273C Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 07/13/2005 | CN1210270C Novel use of phenylheteroalkylamine derivatives |
| 07/13/2005 | CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 07/13/2005 | CN1210256C Diacylhydrazine derivs |
| 07/13/2005 | CN1210066C Cloning pigs using donor nuclei from differentiated cells |
| 07/13/2005 | CN1210059C Fracture healing using PTHrp analogs |
| 07/13/2005 | CN1210055C Moschus safflower capsules for treating femoral necrosis, myelitis and fracture |
| 07/13/2005 | CN1210043C Chinese herbal medicine for treating pains of neck shoulder, waist and legs |
| 07/13/2005 | CN1210037C Glucosamine and egg for reducing inflammation |
| 07/13/2005 | CN1210019C II type collagen water soluble dispersion composition, its preparation method and application |
| 07/12/2005 | US6917616 Method and apparatus for reduction and restoration of data elements pertaining to transmitted data packets in a communications network |
| 07/12/2005 | US6916907 Comprises osteoclastogenesis inhibitory factor (OCIF) polypeptide for diagnosis and treatment of bone disorders |
| 07/12/2005 | US6916838 1-benzylpyrazole-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 07/12/2005 | US6916834 Preparations and use of an Ah receptor ligand, 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 07/12/2005 | US6916817 Inhibitors of metalloproteinases |
| 07/12/2005 | US6916815 C-6 modified indazolylpyrrolotriazines |
| 07/12/2005 | US6916814 Methods of treating cytokine mediated diseases |
| 07/12/2005 | US6916810 αν integrin receptor antagonists |
| 07/12/2005 | US6916809 Heterocyclic acridone inhibitors of IMPDH enzyme |
| 07/12/2005 | US6916807 Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 07/12/2005 | US6916804 Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 07/12/2005 | US6916798 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease |
| 07/12/2005 | US6916791 Androgen glycosides useful as contraceptives, for increasing muscle mass, and treatment of a hypogonadal disorder, androgen deficiency, sexual dysfunction and osteoporosis |
| 07/12/2005 | US6916603 Administering a test agent; monitoring expression of Delta FosB to determine whether the agent modulates bone formation |
| 07/12/2005 | CA2341739C Quinolin-2-one derivatives useful as anticancer agents |
| 07/07/2005 | WO2005061551A1 Carboxy-reduced derivatives of chondroitin sulphate, method of preparing said derivatives, application thereof as a medicament and pharmaceutical compositions containing same |
| 07/07/2005 | WO2005061549A1 Carboxy-reduced derivatives of dermatan sulphate, method of preparing said derivatives, application thereof as a medicament and pharmaceutical compositions containing same |
| 07/07/2005 | WO2004004779A8 Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 07/07/2005 | US20050149995 Using transgenic animal cells as bioreactor for propagation of connective tissue protein for use in treatment of collagen diseases |
| 07/07/2005 | US20050148763 Peg-binding pth or peg-binding pth derivative |
| 07/07/2005 | US20050148664 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine |
| 07/07/2005 | US20050148644 Ligands for Inosine-5'-monophosphate dehydrogenase; antiviral, antiinflammatory, antibiotics, transplant rejection, autoimmune disease, , antipsoriatic immunosuppressants; 3-uriedo benzyl carbamate derivatives; high potency, side effects reduction; bioavailability; antivascular hyperproliferative |
| 07/07/2005 | US20050148636 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 07/07/2005 | US20050148624 Enzyme inhibitors with isoquinolinone structures |
| 07/07/2005 | US20050148608 Chymase enzyme inhibitors for drugs in vascular systems using sulfonylurea derivatives |
| 07/07/2005 | US20050148604 Increase the intracellular cAMP level and further inhibit the activation of T cells; allergic diseases, inflammatory or immunological diseases |
| 07/07/2005 | US20050148588 LFA-1 antagonist compounds |
| 07/07/2005 | US20050148578 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 07/07/2005 | US20050148577 2-methyl-1,8-dioxa-dibenzo[e,h]azulene; potentiation; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 07/07/2005 | US20050148576 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics |
| 07/07/2005 | US20050148575 (Di)Azepino[5,4,3-cd]benzothiophenes; poly(ADP-ribose) polymerase (PARP) and glycohydrolase (PARG) inhibitor; antiinflammatory; protects cells, tissue and organs against the ill-effects of reactive free radicals and nitric oxide, and damage following focal ischemia and reperfusion injury |
| 07/07/2005 | US20050148553 Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis |
| 07/07/2005 | US20050148537 Immunostimulatory nucleic acid molecules |
| 07/07/2005 | US20050148515 Peptidomimetics; determining ability to bind growth hormone secretagogue; ghrelin agonists; appetite stimulation; dietetics |
| 07/07/2005 | US20050148510 Protein with a hedgehog N-terminal domain covalently bound to a polypeptide with 10-30 hydrophobic amino acids, C 8-24 aliphatic, saturated or unsaturated hydrocarbon residues, or a hydrophobic thio group |
| 07/07/2005 | US20050148504 Cysteine protease inhibitor |
| 07/07/2005 | US20050148498 Metalloprotease inhibiting activity, in particular collagenase and gelatinase, treating humans or mammals suffering from a condition or disease related to excessive degeneration of support by a metalloprotease; treat inflammatory diseases: arthrosis, parodontosis or ulcers |
| 07/07/2005 | US20050148034 Using reduced microvessel outgrowth of pluripotent stem cells as diagnostic indicator angoigenseis inhibition; antitumor agents |
| 07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
| 07/07/2005 | US20050147665 Consisting of eicosapentaenoic acid or derivative, vitamin B 12, folic acid, at a maximum daily dose of 5 mg, and vitamin B6, at a maximum daily dose of 20 mg, and optionally at least one antioxidant; treatment of psychiatric disorders; schizophrenia, Alzheimer's disease, dementia, Parkinson's disease |
| 07/07/2005 | US20050147612 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 07/07/2005 | US20050147567 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 07/07/2005 | CA2550300A1 Polymetaphosphate based formulations for therapy of microcrystalline arthropathies |
| 07/07/2005 | CA2549935A1 Treatment of conditions that present with low bone mass by continuous combination therapy with selective prostaglandin ep4 receptor agonists and an estrogen |
| 07/07/2005 | CA2549510A1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors |
| 07/07/2005 | CA2548494A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 07/07/2005 | CA2548462A1 Medicament comprising ptx3, alone or in combination with tsg-6, for treating degenerative diseases of cartilage and bone and treating female infertility |
| 07/07/2005 | CA2548452A1 Medicament comprising inhibitors of long pentraxin ptx3 |
| 07/07/2005 | CA2547617A1 Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cytokine inhibitors |
| 07/07/2005 | CA2546943A1 Novel compounds |
| 07/06/2005 | EP1550660A1 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |